Data / Drug companies / Alendronate sodium
Alendronate sodium: 16 companies and 34 products in the FDA NDC directory
Alendronate sodium is listed in the FDA National Drug Code Directory by 16 companies, with 34 products in commercial distribution. 32 of the products (94.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; tablet, effervescent, and the newest product started marketing on May 24, 2023.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 34
- Generic (ANDA) products
- 32 (94.1%)
- Application numbers
- 8
- Routes
- Oral
- Brand names
- Alendronate, Fosamax, Binosto
- openFDA record search
- api.fda.gov
Companies that list alendronate sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | 5 | tablet | Generic drugs (ANDA) | February 6, 2008 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| NorthStar Rx LLC | 3 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Cipla USA Inc. | 2 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Exelan Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | February 2, 2021 |
| Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. | 2 | tablet | Generic drugs (ANDA) | December 5, 2017 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | May 16, 2018 |
| Ani Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | May 24, 2023 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution | Generic drugs (ANDA) | October 30, 2020 |
| Organon LLC | 1 | tablet | New drug applications (NDA) | June 1, 2021 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | March 30, 2018 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | August 4, 2008 |
| Radius Health, Inc. | 1 | tablet, effervescent | New drug applications (NDA) | March 12, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 31 | 91.2% |
| Solution | 2 | 5.9% |
| Tablet, effervescent | 1 | 2.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 32 | 94.1% |
| New drug applications (NDA) | 2 | 5.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Bisphosphonate | 34 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.